8-K: Huron Reports Strong Q4, Full-Year 2025 Results; Boosts 2026 Outlook

Sentiment:

Quarterly and Annual Results


Huron Consulting Group Inc. announced robust fourth-quarter and full-year 2025 financial results, driven by strong demand in healthcare and commercial segments, and provided optimistic 2026 guidance.

Better than expectedRevenues before reimbursable expenses increased 11.3% in Q4 2025 and 11.9% for the full year 2025, reaching a record $1.66 billion.Adjusted EBITDA increased 19.7% in Q4 2025 and 18.1% for the full year 2025, demonstrating strong operational performance.Adjusted diluted earnings per share increased 14.2% in Q4 2025 and 21.0% for the full year 2025, indicating robust profitability growth on an adjusted basis.The company provided strong 2026 guidance, projecting continued growth in revenue, adjusted EBITDA margin, and adjusted diluted EPS, signaling an optimistic outlook.

Summary

  • Revenues before reimbursable expenses increased 11.3% to $432.3 million in Q4 2025 from $388.4 million in Q4 2024.
  • Net income was $30.7 million in Q4 2025, compared to $34.0 million in Q4 2024, impacted by $2.2 million of contingent consideration remeasurement charges, net of tax.
  • Adjusted EBITDA increased 19.7% to $68.0 million in Q4 2025 from $56.8 million in Q4 2024.
  • Diluted earnings per share was $1.72 in Q4 2025, compared to $1.84 in Q4 2024, impacted by contingent consideration remeasurement charges.
  • Adjusted diluted earnings per share increased 14.2% to $2.17 in Q4 2025 from $1.90 in Q4 2024.
  • Full year 2025 revenues before reimbursable expenses increased 11.9% to a record $1.66 billion from $1.49 billion in 2024.
  • Full year 2025 net income was $105.0 million, compared to $116.6 million in 2024, impacted by $7.7 million of non-cash impairment charges, net of tax.
  • Full year 2025 Adjusted EBITDA increased 18.1% to $237.5 million from $201.2 million in 2024.
  • Full year 2025 diluted earnings per share was $5.84, compared to $6.27 in 2024, impacted by non-cash impairment charges.
  • Full year 2025 Adjusted diluted earnings per share increased 21.0% to $7.83 from $6.47 in 2024.
  • Huron returned $166.2 million to shareholders in 2025 by repurchasing 1.2 million shares, representing 6.6% of common stock outstanding as of December 31, 2024.
  • The board of directors authorized an increase to the company's share repurchase program from $700 million to $900 million on February 19, 2026.
  • Full year 2026 guidance includes revenue expectations in a range of $1.78 billion to $1.86 billion, adjusted EBITDA as a percentage of revenues before reimbursable expenses in a range of 14.5% to 15.0%, and adjusted diluted earnings per share in a range of $8.35 to $9.15.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance report, with significant growth in key adjusted financial metrics and optimistic forward guidance, despite some GAAP net income and EPS declines due to one-time items in both periods.

Positives

  • Achieved record full-year revenues before reimbursable expenses of $1.66 billion in 2025, an 11.9% increase over 2024.
  • Reported strong Q4 2025 revenue growth of 11.3% to $432.3 million.
  • Adjusted EBITDA increased significantly by 19.7% in Q4 2025 to $68.0 million and 18.1% for the full year 2025 to $237.5 million.
  • Adjusted diluted earnings per share grew 14.2% in Q4 2025 to $2.17 and 21.0% for the full year 2025 to $7.83.
  • Achieved organic revenue growth of 5.2% in Q4 2025 and 7.1% for the full year 2025, excluding acquisitions and divestitures.
  • Increased utilization rates for Consulting capability to 77.7% in Q4 2025 (from 77.2% in Q4 2024) and Digital capability to 79.7% (from 77.7% in Q4 2024).
  • The number of revenue-generating professionals increased 13.1% (excluding Managed Services) and Managed Services professionals increased 46.3%.
  • The board authorized an increase to the share repurchase program from $700 million to $900 million, demonstrating confidence in future cash flow.
  • Provided positive 2026 guidance for revenue, adjusted EBITDA margin, and adjusted diluted EPS, indicating continued growth expectations.
  • Experienced strong demand for Consulting and Managed Services capabilities within the Healthcare and Commercial segments, and Digital capability within the Commercial segment.

Negatives

  • Net income decreased in Q4 2025 to $30.7 million from $34.0 million in Q4 2024, primarily due to $2.2 million of contingent consideration remeasurement charges.
  • Net income decreased for the full year 2025 to $105.0 million from $116.6 million in 2024, primarily due to $7.7 million of non-cash impairment charges related to a convertible debt investment.
  • Diluted earnings per share decreased in Q4 2025 to $1.72 from $1.84 in Q4 2024, impacted by contingent consideration remeasurement charges.
  • Diluted earnings per share decreased for the full year 2025 to $5.84 from $6.27 in 2024, impacted by non-cash impairment charges.
  • Q4 2024 results included a $2.4 million gain from the divestiture of the Studer Education business, making Q4 2025 GAAP net income appear comparatively lower.
  • Full year 2024 results included an $11.1 million litigation settlement gain, making full year 2025 GAAP net income appear comparatively lower.
  • Experienced decreases in demand for the company's Digital capability within the Healthcare segment.

Risks

  • Failure to achieve expected utilization rates, billing rates, and the necessary number of revenue-generating professionals.
  • Inability to expand or adjust service offerings in response to market demands.
  • Dependence on renewal of client-based services.
  • Dependence on new business and retention of current clients and qualified personnel.
  • Failure to maintain third-party provider relationships and strategic alliances.
  • Inability to license technology to and from third parties.
  • The impairment of goodwill.
  • Various factors related to income and other taxes.
  • Difficulties in successfully integrating acquired businesses and achieving expected benefits from such acquisitions.
  • Risks relating to privacy, information security, and related laws and standards.
  • A general downturn or volatility in market conditions, including as a result of current global trade tensions and/or tariffs.

Future Outlook

Huron provides full year 2026 guidance, expecting revenues before reimbursable expenses between $1.78 billion and $1.86 billion, adjusted EBITDA as a percentage of revenues before reimbursable expenses in the range of 14.5% to 15.0%, and adjusted diluted earnings per share between $8.35 and $9.15. The company also highlighted the impact of advancing technology, including artificial intelligence (AI), on its guidance and market opportunities.

Management Comments

  • "We finished 2025 with strong fourth-quarter results. Revenues before reimbursable expenses (RBR) grew 11% in the fourth quarter of 2025, driven by record RBR in the healthcare and commercial segments. We also continued our trajectory of margin expansion in the quarter." Mark Hussey, chief executive officer and president of Huron.
  • "Full year RBR grew 12% over 2024, resulting in record RBR and a fifth consecutive year of growth. We are pleased with our continued margin and earnings per share expansion in 2025, including achieving adjusted diluted earnings per share growth of 21% over 2024." Mark Hussey, chief executive officer and president of Huron.
  • "Our market-tested strategy, balanced portfolio of offerings, and strong execution by our highly talented team has delivered strong multi-year financial performance for our business and our shareholders consistent with the financial goals outlined at our investor day." Mark Hussey, chief executive officer and president of Huron.
  • "We believe the ongoing pressures facing our clients and primary end markets will continue to create significant near-term and long-term growth opportunities for Huron. We continue to help our clients solve their most complex challenges through our deep client relationships, industry and advanced technology expertise, including artificial intelligence (AI), and proven track record of delivering tangible results." Mark Hussey, chief executive officer and president of Huron.
  • "We believe the continued strong demand for our services in the market position us well for continued achievement of the financial goals outlined at our 2025 investor day." Mark Hussey, chief executive officer and president of Huron.

Industry Context

StockSavvy.ai notes that Huron's strong performance, particularly in its Healthcare and Commercial segments, aligns with broader industry trends of increased demand for specialized consulting and managed services. The emphasis on "advancing technology, such as artificial intelligence (AI)" positions Huron to capitalize on the growing digital transformation needs across various sectors, indicating a strategic alignment with current technological shifts and client pressures for efficiency and innovation.

Comparison to Industry Standards

  • The filing does not provide specific comparable companies, projects, or results to assess against global benchmarks.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Share Repurchase Program IncreaseHuron's board of directors authorized an increase to the company's share repurchase program from $700 million to $900 million.February 19, 2026Indicates management's confidence in future cash flow and commitment to returning capital to shareholders, potentially boosting shareholder value.

Stakeholder Impact

  • Shareholders: Positive impact due to strong financial performance, increased share repurchase program, and optimistic 2026 guidance, suggesting potential for increased shareholder value.
  • Employees: Increased number of revenue-generating professionals (up 13.1% excluding Managed Services, 46.3% for Managed Services) indicates growth and hiring, suggesting positive employment opportunities.
  • Customers: Continued strong demand for services, including advanced technology expertise like AI, suggests clients are finding value in Huron's offerings to solve complex challenges.

Next Steps

  • Huron will host a webcast on February 24, 2026, at 5:00 p.m. Eastern Time to discuss its financial results.
  • Huron's forthcoming Annual Report on Form 10-K filing for the year ended December 31, 2025, will include additional financial results by operating industry.

Key Dates

DateDescription
February 19, 2026Huron's board of directors authorized an increase to the company's share repurchase program from $700 million to $900 million.
February 24, 2026Date of report (earliest event reported), press release issued announcing financial results for Q4 and full year 2025, and webcast to discuss financial results.
December 31, 2025End of the fourth quarter and full fiscal year for which financial results are reported.

Recommendation

strong buy

The company delivered robust adjusted financial results for both Q4 and the full year 2025, demonstrating strong organic growth and margin expansion. The significant increase in the share repurchase program and optimistic 2026 guidance, which includes leveraging AI, signals strong management confidence and a clear path for continued growth and shareholder returns. Despite some GAAP net income and EPS declines due to one-time items, the underlying business performance and future outlook are very positive.

Keywords

Huron Consulting Group, HURN, financial results, Q4 2025, full year 2025, 2026 guidance, revenue, adjusted EBITDA, EPS, share repurchase, professional services, consulting, managed services, digital transformation, healthcare, education, commercial, artificial intelligence, AI

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.